The Food and Drug Administration hailed the potential of the first-of-its-kind device to counter the U.S. phlebotomist shortage.
Vitestro secures FDA nod for robotic blood draw device
Vitestro secures FDA nod for robotic blood draw device is a pharma and life sciences industry update from MedTech Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Source: MedTech Dive